All South Texas Blood & Tissue Center donor rooms will be closed on Monday, Feb. 15 and all blood drives that day will be canceled because of the severe winter weather across South Texas.
Virtually everyone in a study in the United Kingdom who had COVID-19 still had antibodies to it in their systems three months after recovering, and almost nine in 10 had them after six months.
The first-of-its-kind civilian program to provide low-titer O-positive whole blood for emergency use, of which the Brothers in Arms program from the South Texas Blood & Tissue Center is a key component, has been highlighted in the latest edition of the journal Military Medicine.
When you register to be an organ, eye and tissue donor while renewing your Texas driver’s license or ID, you’ll earn a “hero’s heart” insignia on your new card.
National blood shortages can have dramatic impact on South Texas patients On Monday and Tuesday of this week, the South Texas Blood & Tissue Center distributed more than 1,081 units
For more than 45 years, the nonprofit South Texas Blood & Tissue Center has focused on a critical purpose: to save and improve lives.
Inspired by a group of physicians, our organization was formed to provide blood to the South Texas region – ensuring a safe and adequate blood supply through proper testing, storage and distribution to hospitals. This essential service allows front-line workers to focus on the direct care of patients, with confidence that this lifesaving resource will be there when it’s needed most.
But we didn’t stop there. Over the years, we’ve evolved as the needs of our patients and hospitals have changed, driven to save lives in as many ways as possible.
We couldn’t do this without donors like you. We understand that the gift of donation is a personal, powerful choice that has the potential to touch a life. Today, we offer many ways to make a difference that include:
Our team has also expanded its programs, partnering with leaders within the healthcare industry to develop a wide range of therapies. We’ve recently developed programs to collect and distribute COVID-19 convalescent plasma, as well as improve trauma care.